Author

J. van der Meulen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:metabolomics· 1 Approach:statistical model· 1

Frequent Co-Authors

E. De Thaye· 1 shared F. Maza· 1 shared G. Beckh· 1 shared G. Berx· 1 shared G. Wagemans· 1 shared H. Denys· 1 shared I. Esperanca· 1 shared J. Taminau· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

E. De Thaye

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BiochemistrybioRxivPreprintMay 17, 2022

Impact of genus (Geotrigona, Melipona, Scaptotrigona) in the 1H-NMR organic profile and authenticity test of honey processed in cerumen pots by stingless bees in Ecuador

P. Vit, J. van der Meulen, S. R. Pedro…·F. Maza

This paper analyzes 1H-NMR profiles and authenticity of Ecuadorian pot-honey from three stingless bee genera, identifying genus-specific metabolites and developing a biosurfactant test for classification.

DOI 10.1101/2022.05.17.492391

metabolomicsstatistical model

𝕏 PostBluesky

Cancer BiologybioRxivSep 27, 2019

Establishment and characterization of a cell line and patient-derived xenograft (PDX) from peritoneal metastasis of low-grade serous ovarian carcinoma

E. De Thaye, K. Van de Vijver, J. Van der Meulen…·O. De Wever

The paper establishes and characterizes a PDX model and cell line from peritoneal metastasis of low-grade serous ovarian carcinoma, showing sensitivity to paclitaxel and trametinib.

DOI 10.1038/s41598-020-63738-6

humanbulk RNA-seq

𝕏 PostBluesky